Status:

ACTIVE_NOT_RECRUITING

Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication

Lead Sponsor:

Diakonhjemmet Hospital

Collaborating Sponsors:

University Hospital, Akershus

Conditions:

Rheumatoid Arthritis

Psoriatic Arthritis

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to assess the strength and duration of the immunological response to COVID-19 vaccines in patients treated with immunosuppressive and/or immunomodulating medication for im...

Detailed Description

Patients on long-term immunosuppressive and/or immunomodulating medication may be susceptible to serious COVID-19. Hence, it is important they get sufficient protection by a COVID-19 vaccine. However,...

Eligibility Criteria

Inclusion

  • An established clinical diagnosis of one of the following immune-mediated diseases: rheumatoid arthritis (RA), spondyloarthritis (SpA), psoriatic arthritis (PsA), ulcerative colitis (UC,) Crohns disease (CD), autoimmune hepatitis (AIH) or patients who have undergone a liver transplantation
  • Treatment with relevant immunosuppressive and/or immunomodulating medication \*
  • Adult patients (\> 18 years)
  • Patient intends to obtain vaccination against COVID-19 during the next 6 months
  • \* The following drugs are considered relevant immunosuppressants and/or immunomodulators and patients using them may be eligible for this study: Rituximab, infliximab, adalimumab, golimumab, certolizumab, etanercept, tocilizumab, abatacept, secukinumab, vedolizumab, ustekinumab, risankizumab, methotrexate, sulfasalazine, leflunomide, azathioprine, 6-mercaptopurine, tofacitinib, filgotinib, baricitinib, upadacitinib, tacrolimus, mycophenolate, prednisolone

Exclusion

  • 1\) Allergy or intolerance to elements of the COVID-19 vaccines
  • \-

Key Trial Info

Start Date :

February 15 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 15 2027

Estimated Enrollment :

2300 Patients enrolled

Trial Details

Trial ID

NCT04798625

Start Date

February 15 2021

End Date

February 15 2027

Last Update

February 23 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Akershus University Hospital

Lørenskog, Norway

2

Diakonhjemmet Hospital

Oslo, Norway